CNR1 and kidney disorder: In accordance with these data, evidence from a series of studies using animal models of cisplatin-induced nephropathy [44–47], in which it has been demonstrated that blocking the CB1R [45] or activating the CB2R [46, 47] can attenuate the cisplatin-induced increase of oxidative stress and the associated inflammation, thus protecting against renal tubular damage.